Study of treatment for advanced cancer that has spread.
Part of Cancer clinical trials.
This trial is for people with advanced cancer that has spread and is considered terminal. It aims to test a new treatment to see if it can help people in this situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread to other parts of the body.
- Your doctor has told you that the cancer is terminal (not curable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.
This trial is a compassionate-use program for a single patient with prostate cancer that has returned after initial treatment. It provides access to an experimental drug called MBM-02 (tempol), which is not yet approved, when other options are limited.
This trial tests a new drug that targets a protein called MET found on some cancer cells. It may help people with certain advanced cancers that have not responded to other treatments.
This trial tests a new drug called tarlatamab for people with advanced small cell or neuroendocrine cancers that started outside the lung (like in the stomach, bladder, or head and neck) and have grown after initial chemotherapy. It aims to see if this treatment can shrink or control the cancer.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
Hear when a new Metastatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.